CB Insights’ second annual Digital Health 150 list includes 26 startups seeking to improve drug research and development, an area hard-hit as the COVID-19 pandemic interrupts clinical trials.
Drug discovery companies include Healx (rare diseases) and ProteinQure (quantum computing). (Download the full report here.)
Get the full story on our sister site Medical Design & Outsourcing.
Check out this chart with the logos of the 150 companies:
Filed Under: clinical trials, Drug Discovery, Drug Discovery and Development